{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Nondiabetic", "adipokine", "functional outcome", "ischemic stroke", "omentin-1"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30972209", "DateRevised": {"Year": "2020", "Month": "09", "Day": "30"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "03", "Day": "15"}], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1943-8141", "JournalIssue": {"Volume": "11", "Issue": "3", "PubDate": {"Year": "2019"}}, "Title": "American journal of translational research", "ISOAbbreviation": "Am J Transl Res"}, "ArticleTitle": "Impact of serum omentin-1 levels on functional prognosis in nondiabetic patients with ischemic stroke.", "Pagination": {"StartPage": "1854", "EndPage": "1863", "MedlinePgn": "1854-1863"}, "Abstract": {"AbstractText": ["Omentin-1, an adipokine released from visceral fat tissue, is associated with diabetes and stroke. The purpose of this study was to assess the impact of serum omentin-1 levels on functional prognosis in nondiabetic patients with ischemic stroke.", "From March 2016 to December 2017, consecutive patients with first-ever ischemic stroke admitted to our hospital, China, were recorded. Functional impairment was evaluated at 3-month after admission using the modified Rankin scale (mRS). Uni-and multivariate analyses with Cox proportional hazard regression was used for assessing the relationship between serum level of omentin-1 and functional outcome.", "We recorded 209 stroke patients, 52 of them (24.9%) experienced as poor functional outcome. The obtained omentin-1 level in patients with poor outcome was lower than in those patients with good outcome [100.8 (80.9-131.6) ng/ml vs. 137.6 (IQR, 106.1-171.5) ng/ml; Z=4.692; P<0.001). Multivariate analysis models were used to assess stroke outcome according to omentin-1 quartiles (the highest quartile [Q4] as the reference), the 1<sup>st</sup> and 2<sup>nd</sup> quartile of omentin-1 were compared against the Q4, and the risks were increased by 505% (HR=6.05; 95% CI: 2.13-12.15; P=0.007) and 215% (31.5; 1.21-7.98; P=0.03), respectively. The inclusion of omentin-1 in the routine prediction model for the prediction of poor functional outcome, enhanced the NRI (P=0.006) and IDI (P=0.001) values, confirming the effective reclassification and discrimination. Kaplan-Meier analysis suggested that the patients with low serum omentin-1 levels had a higher risk of death than those patients with high levels of omentin-1 (log-rank test P=0.033).", "In this cohort of nondiabetic patients with ischemic stroke, a reduced baseline level of serum omentin-1 was related with an increased risk for poor functional outcome or death, independent of baseline variables."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Wu", "ForeName": "Dong-Mei", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Wang", "ForeName": "Shan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Wen", "ForeName": "Xin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Han", "ForeName": "Xin-Rui", "Initials": "XR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Wang", "ForeName": "Yong-Jian", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Shen", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Fan", "ForeName": "Shao-Hua", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Zhang", "ForeName": "Zi-Feng", "Initials": "ZF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Shan", "ForeName": "Qun", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Li", "ForeName": "Meng-Qiu", "Initials": "MQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Hu", "ForeName": "Bin", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Lu", "ForeName": "Jun", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University Nanjing 210061, P. R. China."}], "LastName": "Chen", "ForeName": "Gui-Quan", "Initials": "GQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University Xuzhou 221116, P. R. China."}, {"Identifier": [], "Affiliation": "College of Health Sciences, Jiangsu Normal University Xuzhou 221116, P. R. China."}], "LastName": "Zheng", "ForeName": "Yuan-Lin", "Initials": "YL"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Transl Res", "NlmUniqueID": "101493030", "ISSNLinking": "1943-8141"}, "CoiStatement": "None."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Guan T, Ma J, Li M, Xue T, Lan Z, Guo J, Shen Y, Chao B, Tian G, Zhang Q, Wang L, Liu Y. Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013. Neurology. 2017;89:53\u201361.", "ArticleIdList": ["28566547"]}, {"Citation": "Tu WJ, Zhao SJ, Xu DJ, Chen H. Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischaemic stroke. Clin Sci. 2014;126:339\u2013346.", "ArticleIdList": ["24020395"]}, {"Citation": "Tu WJ, Ma GZ, Ni Y, Hu XS, Luo DZ, Zeng XW, Liu Q, Xu T, Yu L, Wu B. Copeptin and NT-proBNP for prediction of all-cause and cardiovascular death in ischemic stroke. Neurology. 2017;88:1899\u20131905.", "ArticleIdList": ["28424274"]}, {"Citation": "Bouziana S, Tziomalos K, Goulas A, Hatzitolios AI. The role of adipokines in ischemic stroke risk stratification. Int J Stroke. 2016;11:389\u2013398.", "ArticleIdList": ["26873941"]}, {"Citation": "Yang H, Guo W, Li J, Cao S, Zhang J, Pan J, Wang Z, Wen P, Shi X, Zhang S. Leptin concentration and risk of coronary heart disease and stroke: a systematic review and meta-analysis. PLoS One. 2017;12:e0166360.", "ArticleIdList": ["PMC5344319", "28278178"]}, {"Citation": "Gorgui J, Gasbarrino K, Georgakis MK, Karalexi MA, Nauche B, Petridou ET, Daskalopoulou SS. Circulating adiponectin levels in relation to carotid atherosclerotic plaque presence, ischemic stroke risk, and mortality: a systematic review and meta-analyses. Metabolism. 2017;69:51\u201366.", "ArticleIdList": ["28285652"]}, {"Citation": "Liu C, Che Y. Retinol-binding protein 4 predicts lesion volume (determined by MRI) and severity of acute ischemic stroke. Neurotox Res. 2019;35:92\u201399.", "ArticleIdList": ["30030781"]}, {"Citation": "Bustamante A, Sobrino T, Giralt D, Garc\u00eda-Berrocoso T, Llombart V, Ugarriza I, Espadaler M, Rodr\u00edguez N, Sudlow C, Castellanos M, Smith CJ, Rodr\u00edguez-Y\u00e1nez M, Waje-Andreassen U, Tanne D, Oto J, Barber M, Worthmann H, Wartenberg KE, Becker KJ, Chakraborty B, Oh SH, Whiteley WN, Castillo J, Montaner J. Prognostic value of blood interleukin-6 in the prediction of functional outcome after stroke: a systematic review and meta-analysis. J Neuroimmunol. 2014;274:215\u2013224.", "ArticleIdList": ["25091431"]}, {"Citation": "Yue J, Chen J, Wu Q, Liu X, Li M, Li Z, Gao Y. Serum levels of omentin-1 association with early diagnosis, lesion volume and severity of acute ischemic stroke. Cytokine. 2018;111:518\u2013522.", "ArticleIdList": ["29880272"]}, {"Citation": "de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M, Fried SK, Gong DW, Shuldiner AR, Pollin TI, McLenithan JC. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007;56:1655\u20131661.", "ArticleIdList": ["17329619"]}, {"Citation": "Shibata R, Ouchi N, Takahashi R, Terakura Y, Ohashi K, Ikeda N, Higuchi A, Terasaki H, Kihara S, Murohara T. Omentin as a novel biomarker of metabolic risk factors. Diabetol Metab Syndr. 2012;4:37.", "ArticleIdList": ["PMC3411496", "22835063"]}, {"Citation": "Tan BK, Adya R, Randeva HS. Omentin: a novel link between inflammation, diabesity, and cardiovascular disease. Trends Cardiovasc Med. 2010;20:143\u2013148.", "ArticleIdList": ["21742269"]}, {"Citation": "Tan BK, Adya R, Farhatullah S, Lewandowski KC, O\u2019Hare P, Lehnert H, Randeva HS. Omentin-1, a novel adipokine, is decreased in overweight insulin resistant women with the polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes. 2008;57:801\u20138.", "ArticleIdList": ["18174521"]}, {"Citation": "Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol. 2011;10:103.", "ArticleIdList": ["PMC3235986", "22108456"]}, {"Citation": "Liu R, Wang X, Bu P. Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract. 2011;93:21\u201325.", "ArticleIdList": ["21497934"]}, {"Citation": "Zhong X, Zhang H, Tan H, Zhou Y, Liu FL, Chen FQ, Shang DY. Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin. 2011;32:873\u20138.", "ArticleIdList": ["PMC4003121", "21602837"]}, {"Citation": "Greulich S, Chen WJ, Maxhera B, Rijzewijk LJ, van der Meer RW, Jonker JT, Mueller H, de Wiza DH, Floerke RR, Smiris K, Lamb HJ, de Roos A, Bax JJ, Romijn JA, Smit JW, Akhyari P, Lichtenberg A, Eckel J, Diamant M, Ouwens DM. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLoS One. 2013;8:e59697.", "ArticleIdList": ["PMC3612072", "23555749"]}, {"Citation": "Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. 2010;393:668\u2013672.", "ArticleIdList": ["20170632"]}, {"Citation": "Kadoglou NP, Lambadiari V, Gastounioti A, Gkekas C, Giannakopoulos TG, Koulia K, Maratou E, Alepaki M, Kakisis J, Karakitsos P, Nikita KS, Dimitriadis G, Liapis CD. The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability. Atherosclerosis. 2014;235:606\u2013612.", "ArticleIdList": ["24956535"]}, {"Citation": "Menzel J, di Giuseppe R, Biemann R, Wittenbecher C, Aleksandrova K, Pischon T, Fritsche A, Schulze MB, Boeing H, Isermann B, Weikert C. Omentin-1 and risk of myocardial infarction and stroke: results from the EPIC-Potsdam cohort study. Atherosclerosis. 2016;251:415\u2013421.", "ArticleIdList": ["27298015"]}, {"Citation": "Xu T, Zuo P, Wang Y, Gao Z, Ke K. Serum omentin-1 is a novel biomarker for predicting the functional outcome of acute ischemic stroke patients. Clin Chem Lab Med. 2018;56:350\u2013355.", "ArticleIdList": ["28708570"]}, {"Citation": "Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D\u2019Agostino RB, Wolf PA. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham offspring study. Arch Intern Med. 2006;166:106\u2013111.", "ArticleIdList": ["16401818"]}, {"Citation": "Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, Kamouchi M Fukuoka Stroke Registry Investigators. Insulin resistance and clinical outcomes after acute ischemic stroke. Neurology. 2018;90:e1470\u2013e1477.", "ArticleIdList": ["29602916"]}, {"Citation": "G\u00fcrsoy G, K\u0131rnap NG, E\u015fbah O, et al. The relationship between plasma omentin-1 levels and insulin resistance in newly diagnosed type 2 diabet\u0131c women. Clinical Reviews and Opinions. 2010;2:49\u201354."}, {"Citation": "Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54:541\u201353.", "ArticleIdList": ["PMC2366492", "1088404"]}, {"Citation": "Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24:35\u201341.", "ArticleIdList": ["7678184"]}, {"Citation": "Bonita R, Beaglehole R. Modification of rankin scale: recovery of motor function after stroke. Stroke. 1988;19:1497\u20131500.", "ArticleIdList": ["3201508"]}, {"Citation": "Tu WJ, Zeng XW, Deng A, Zhao SJ, Luo DZ, Ma GZ, Wang H, Liu Q. Circulating FABP4 (fatty acid-binding protein 4) is a novel prognostic biomarker in patients with acute ischemic stroke. Stroke. 2017;48:1531\u20131538.", "ArticleIdList": ["28487339"]}, {"Citation": "Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157\u2013172.", "ArticleIdList": ["17569110"]}, {"Citation": "Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong DW. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006;290:E1253\u201361.", "ArticleIdList": ["16531507"]}, {"Citation": "Wittenbecher C, Menzel J, Carstensen-Kirberg M, Biemann R, di Giuseppe R, Fritsche A, Isermann B, Herder C, Aleksandrova K, Boeing H, Weikert C, Schulze MB. Omentin-1, adiponectin, and the risk of developing type 2 diabetes. Diabetes Care. 2016;39:e79\u2013e80.", "ArticleIdList": ["27208328"]}, {"Citation": "Narumi T, Watanabe T, Kadowaki S, Kinoshita D, Yokoyama M, Honda Y, Otaki Y, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Miyamoto T, Kubota I. Impact of serum omentin-1 levels on cardiac prognosis in patients with heart failure. Cardiovasc Diabetol. 2014;13:84.", "ArticleIdList": ["PMC4006671", "24755035"]}, {"Citation": "Shibata R, Ouchi N, Kikuchi R, Takahashi R, Takeshita K, Kataoka Y, Ohashi K, Ikeda N, Kihara S, Murohara T. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis. 2011;219:811\u2013814.", "ArticleIdList": ["21925659"]}, {"Citation": "Panagiotou G, Mu L, Na B, Mukamal KJ, Mantzoros CS. Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk. Metabolism. 2014;63:1265\u20131271.", "ArticleIdList": ["PMC4175146", "25060690"]}, {"Citation": "Menzel J, Di Giuseppe R, Biemann R, Wittenbecher C, Aleksandrova K, Eichelmann F, Fritsche A, Schulze MB, Boeing H, Isermann B, Weikert C. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study. Sci Rep. 2017;7:14171.", "ArticleIdList": ["PMC5658383", "29075000"]}, {"Citation": "Xu T, Zuo P, Cao L, Gao Z, Ke K. Omentin-1 is associated with carotid plaque instability among ischemic stroke patients. J Atheroscler Thromb. 2018;25:505\u2013511.", "ArticleIdList": ["PMC6005229", "29225325"]}, {"Citation": "Zhou JP, Tong XY, Zhu LP, Luo JM, Luo Y, Bai YP, Li CC, Zhang GG. Plasma omentin-1 level as a predictor of good coronary collateral circulation. J Atheroscler Thromb. 2017;24:940\u2013948.", "ArticleIdList": ["PMC5587520", "28123148"]}, {"Citation": "Shang FJ, Wang JP, Liu XT, Zheng QS, Xue YS, Wang B, Zhao LY. Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers. 2011;16:657\u2013662.", "ArticleIdList": ["21988056"]}, {"Citation": "Tu WJ, Qiu HC, Cao JL, Liu Q, Zeng XW, Zhao JZ. Decreased concentration of irisin is associated with poor functional outcome in ischemic stroke. Neurotherapeutics. 2018;15:1158\u20131167.", "ArticleIdList": ["PMC6277286", "30030698"]}, {"Citation": "Opatrilova R, Caprnda M, Kubatka P, Valentova V, Uramova S, Nosal V, Gaspar L, Zachar L, Mozos I, Petrovic D, Dragasek J, Filipova S, B\u00fcsselberg D, Zulli A, Rodrigo L, Kruzliak P, Krasnik V. Adipokines in neurovascular diseases. Biomed Pharmacother. 2018;98:424\u2013432.", "ArticleIdList": ["29278852"]}, {"Citation": "Wolk R, Bertolet M, Singh P, Brooks MM, Pratley RE, Frye RL, Mooradian AD, Rutter MK, Calvin AD, Chaitman BR, Somers VK BARI 2D Study Group. Prognostic value of adipokines in predicting cardiovascular outcome: explaining the obesity paradox. Mayo Clin Proc. 2016;91:858\u2013866.", "ArticleIdList": ["PMC4935584", "27289411"]}, {"Citation": "Gairolla J, Kler R, Modi M, Khurana D. Leptin and adiponectin: pathophysiological role and possible therapeutic target of inflammation in ischemic stroke. Rev Neurosci. 2017;28:295\u2013306.", "ArticleIdList": ["28121618"]}, {"Citation": "Kadoglou NP, Fotiadis G, Lambadiari V, Maratou E, Dimitriadis G, Liapis CD. Serum levels of novel adipokines in patients with acute ischemic stroke: potential contribution to diagnosis and prognosis. Peptides. 2014;57:12\u201316.", "ArticleIdList": ["24768795"]}, {"Citation": "Has\u0131rc\u0131 B, Ko\u00e7er A, Toprak A, et al. The relationship between prognosis and serum chemerin levels in acute ischemic stroke patients. J Neurol Sci. 2015;357:e387."}, {"Citation": "de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003;107:690\u2013695.", "ArticleIdList": ["12578870"]}, {"Citation": "Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. 2010;393:668\u2013672.", "ArticleIdList": ["20170632"]}, {"Citation": "Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun. 2011;408:339\u2013343.", "ArticleIdList": ["21514279"]}, {"Citation": "Pan HY, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract. 2010;88:29\u201333.", "ArticleIdList": ["20129687"]}, {"Citation": "Ohashi K, Shibata R, Murohara T, Ouchi N. Role of anti-inflammatory adipokines in obesity-related diseases. Trends Endocrinol Metab. 2014;25:348\u2013355.", "ArticleIdList": ["24746980"]}, {"Citation": "Kazama K, Usui T, Okada M, Hara Y, Yamawaki H. Omentin plays an anti-inflammatory role through inhibition of TNF-alpha-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol. 2012;686:116\u2013123.", "ArticleIdList": ["22554771"]}, {"Citation": "Moreno-Navarrete JM, Ortega F, Castro A, Sabater M, Ricart W, Fern\u00e1ndez-Real JM. Circulating omentin as a novel biomarker of endothelial dysfunction. Obesity. 2011;19:1552\u20131559.", "ArticleIdList": ["21293447"]}, {"Citation": "Gimbrone MA Jr, Garc\u00eda-Carde\u00f1a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118:620\u2013636.", "ArticleIdList": ["PMC4762052", "26892962"]}]}], "History": [{"Year": "2018", "Month": "11", "Day": "26"}, {"Year": "2018", "Month": "12", "Day": "25"}, {"Year": "2019", "Month": "4", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "3", "Day": "15"}], "PublicationStatus": "epublish", "ArticleIdList": ["30972209", "PMC6456553"]}}]}